MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.

Published in: Journal of psychopharmacology (Oxford, England) (2022)

MDMA/ecstasy and psilocybin use are associated with reduced odds of suicidal thinking and related outcomes-though experimental studies are needed to determine whether these associations are causal. These findings call for more research into the efficacy of MDMA/ecstasy and classic psychedelics for treating psychological distress and suicidal thoughts and behaviors, and for updated drug legislation that allows for further investigation into these substances.

Keyphrases

depressive symptoms
sleep quality
drinking water
emergency department
drug induced
metabolic syndrome
adverse drug
insulin resistance
electronic health record